WuXi STA, a subsidiary of Wuxi AppTec, a contract R&D and manufacturing service provider (CRDMO) for the pharmaceutical and biotech industry, is increasing its regional footprint in Europe, with its newest facility in Couvet, Switzerland. CHEManager spoke with Dr. Jinling Chen, SVP and head of WuXi STA’s pharmaceutical development and manufacturing services, And Jamie Andrews, site head of the Couvet manufacturing site – a facility that the company purchased from Bristol-Myers Squibb in 2021 – to explain the strategy and goals of the European expansion
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.